Cargando…
Breast PET/MRI Hybrid Imaging and Targeted Tracers
The recent introduction of hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) as a promising imaging modality for breast cancer assessment has prompted fervent research activity on its clinical applications. The current knowledge regarding the possible clinical applications of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074861/ https://www.ncbi.nlm.nih.gov/pubmed/36165348 http://dx.doi.org/10.1002/jmri.28431 |
_version_ | 1785019820084822016 |
---|---|
author | Romeo, Valeria Helbich, Thomas H. Pinker, Katja |
author_facet | Romeo, Valeria Helbich, Thomas H. Pinker, Katja |
author_sort | Romeo, Valeria |
collection | PubMed |
description | The recent introduction of hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) as a promising imaging modality for breast cancer assessment has prompted fervent research activity on its clinical applications. The current knowledge regarding the possible clinical applications of hybrid PET/MRI is constantly evolving, thanks to the development and clinical availability of hybrid scanners, the development of new PET tracers and the rise of artificial intelligence (AI) techniques. In this state‐of‐the‐art review on the use of hybrid breast PET/MRI, the most promising advanced MRI techniques (diffusion‐weighted imaging, dynamic contrast‐enhanced MRI, magnetic resonance spectroscopy, and chemical exchange saturation transfer) are discussed. Current and experimental PET tracers ((18)F‐FDG, (18)F‐NaF, choline, (18)F‐FES, (18)F‐FES, (89)Zr‐trastuzumab, choline derivatives, (18)F‐FLT, and (68)Ga‐FAPI‐46) are described in order to provide an overview on their molecular mechanisms of action and corresponding clinical applications. New perspectives represented by the use of radiomics and AI techniques are discussed. Furthermore, the current strengths and limitations of hybrid PET/MRI in the real world are highlighted. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY: Stage 2 |
format | Online Article Text |
id | pubmed-10074861 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100748612023-04-12 Breast PET/MRI Hybrid Imaging and Targeted Tracers Romeo, Valeria Helbich, Thomas H. Pinker, Katja J Magn Reson Imaging Reviews The recent introduction of hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) as a promising imaging modality for breast cancer assessment has prompted fervent research activity on its clinical applications. The current knowledge regarding the possible clinical applications of hybrid PET/MRI is constantly evolving, thanks to the development and clinical availability of hybrid scanners, the development of new PET tracers and the rise of artificial intelligence (AI) techniques. In this state‐of‐the‐art review on the use of hybrid breast PET/MRI, the most promising advanced MRI techniques (diffusion‐weighted imaging, dynamic contrast‐enhanced MRI, magnetic resonance spectroscopy, and chemical exchange saturation transfer) are discussed. Current and experimental PET tracers ((18)F‐FDG, (18)F‐NaF, choline, (18)F‐FES, (18)F‐FES, (89)Zr‐trastuzumab, choline derivatives, (18)F‐FLT, and (68)Ga‐FAPI‐46) are described in order to provide an overview on their molecular mechanisms of action and corresponding clinical applications. New perspectives represented by the use of radiomics and AI techniques are discussed. Furthermore, the current strengths and limitations of hybrid PET/MRI in the real world are highlighted. EVIDENCE LEVEL: 2 TECHNICAL EFFICACY: Stage 2 John Wiley & Sons, Inc. 2022-09-27 2023-02 /pmc/articles/PMC10074861/ /pubmed/36165348 http://dx.doi.org/10.1002/jmri.28431 Text en © 2022 The Authors. Journal of Magnetic Resonance Imaging published by Wiley Periodicals LLC on behalf of International Society for Magnetic Resonance in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Romeo, Valeria Helbich, Thomas H. Pinker, Katja Breast PET/MRI Hybrid Imaging and Targeted Tracers |
title | Breast PET/MRI Hybrid Imaging and Targeted Tracers |
title_full | Breast PET/MRI Hybrid Imaging and Targeted Tracers |
title_fullStr | Breast PET/MRI Hybrid Imaging and Targeted Tracers |
title_full_unstemmed | Breast PET/MRI Hybrid Imaging and Targeted Tracers |
title_short | Breast PET/MRI Hybrid Imaging and Targeted Tracers |
title_sort | breast pet/mri hybrid imaging and targeted tracers |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074861/ https://www.ncbi.nlm.nih.gov/pubmed/36165348 http://dx.doi.org/10.1002/jmri.28431 |
work_keys_str_mv | AT romeovaleria breastpetmrihybridimagingandtargetedtracers AT helbichthomash breastpetmrihybridimagingandtargetedtracers AT pinkerkatja breastpetmrihybridimagingandtargetedtracers |